2. Hubbard AF, et al. Association of adipose and red blood cell lipids with severity of dominant Stargardt macular dystrophy (STGD3) secondary to an ELOVL4 mutation. Arch. of Ophthalmol. 2006 Feb 1;124(2):257-63.
3. Prokopiou E, et al. Omega-3 fatty acids supplementation: Therapeutic potential in a mouse model of Stargardt disease. IOVS. 2018 Jun 1;59(7):2757-2767.